Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
<p>Background</p> Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel...
Autors principals: | Salman, R, Minks, DP, Mitra, D, Rodrigues, MA, Bhatnagar, P, Du Plessis, JC, Joshi, Y, Dennis, MS, Murray, GD, Newby, DE, Sandercock, PAG, Sprigg, N, Stephen, J, Sudlow, CLM, Werring, DJ, Whiteley, WN, Wardlaw, JM, White, PM, Restart Collaboration, Armitage, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2019
|
Ítems similars
-
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
per: Salman, R, et al.
Publicat: (2018) -
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
per: Baigent, C, et al.
Publicat: (2019) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
per: Rustam Al-Shahi Salman, et al.
Publicat: (2018-03-01) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
per: Rustam Al-Shahi Salman, et al.
Publicat: (2019-03-01) -
Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
per: David Werring, et al.
Publicat: (2016-09-01)